Stock URGN UROGEN PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Market Closed - Nasdaq
Other stock markets
 16:00:01 2024-05-31 EDT 		5-day change 1st Jan Change
13.31 USD -1.77% Intraday chart for UroGen Pharma Ltd. +0.53% -11.27%
05-14 Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating MT
05-13 Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
UROGEN PHARMA LTD. Stock UroGen Pharma Ltd.
 481M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. URGN Stock
  4. Charts UroGen Pharma Ltd.
  5. Sector Chart